Back to Search Start Over

Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy.

Authors :
Báez Cabanillas MV
Colque R
Tibaldi MÁ
Kaplinsky E
Perrone S
Barbagelata A
Source :
Drugs in context [Drugs Context] 2023 Jan 04; Vol. 12. Date of Electronic Publication: 2023 Jan 04 (Print Publication: 2023).
Publication Year :
2023

Abstract

Tachycardia-induced cardiomyopathy is an entity characterized by reversible dysfunction of the left ventricle, which can be induced by different types of arrhythmia such as atrial fibrillation, atrial flutter, incessant supraventricular tachycardia and ventricular arrhythmia (more frequent causes). Correct identification of the causative arrhythmia and normalization of the heart rate (e.g through medical treatment, electrical cardioversion, ablation) can lead to recovery of left ventricular function. Tachycardia-induced cardiomyopathy should be suspected in patients with tachycardia and left ventricular dysfunction (heart failure setting), especially when there is no history of previous heart disease. Its usual phenotype is that of non-ischaemic/non-valvular dilated cardiomyopathy and it can occur in both children (main cause: permanent junctional reciprocating tachycardia) and adults (main cause: atrial fibrillation). With proper treatment, most cases recover within a few months, though there is a risk of relapse, especially when the causal arrhythmia reappears or its control is lost. This is a narrative review that comprehensively addresses the pathophysiology, clinical manifestations, and therapeutic management of tachycardia-induced cardiomyopathy. This article is part of the Emerging concepts in heart failure management and treatment Special Issue: https://www.drugsincontext.com/special_issues/emerging-concepts-in-heart-failure-management-and-treatment.<br />Competing Interests: Disclosure and potential conflicts of interest: The authors declare that they have no conflicts of interest relevant to this manuscript. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2022/11/dic.2022-8-4-COI.pdf<br /> (Copyright © 2023 Báez Cabanillas MA, Colque R, Tibaldi MA, Kaplinsky E, Perrone S, Barbagelata A.)

Details

Language :
English
ISSN :
1745-1981
Volume :
12
Database :
MEDLINE
Journal :
Drugs in context
Publication Type :
Academic Journal
Accession number :
36660016
Full Text :
https://doi.org/10.7573/dic.2022-8-4